SMTL ID : 6fek.1

Oncogenic point mutation of RET receptor tyrosine kinase

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

3 x FMT: FORMIC ACID(Non-functional Binders)

FMT.1: 7 residues within 4Å: Chain A: R.159, L.181, R.183, K.193, G.197, R.198, I.199 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:R.159, A:R.159, A:R.183, A:K.193, A:R.198 FMT.2: 4 residues within 4Å: Chain A: G.1, P.2, L.3, S.4 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:G.1, A:L.3, A:S.4, A:S.4 FMT.3: 7 residues within 4Å: Chain A: R.22, C.95, Q.97, D.98, G.99, P.100, L.102 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.22

1 x ADN: ADENOSINE(Non-covalent)

ADN.4: 15 residues within 4Å: Chain A: L.31, G.32, G.34, V.39, A.57, K.59, I.89, V.105, E.106, Y.107, A.108, G.111, S.112, R.164, L.167 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:E.106, A:A.108, A:S.112 Water bridges: A:E.33

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nakaoku, T. et al., A secondary RET mutation in the activation loop conferring resistance to vandetanib. Nat Commun (2018)

Release Date

2018-02-28

Peptides

Proto-oncogene tyrosine-protein kinase receptor Ret: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase receptor Ret